Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro

Abstract Background The accumulation of single nucleotide variants (SNVs) and the emergence of neoantigens can affect tumour proliferation and the immune microenvironment. However, the SNV-related immune microenvironment characteristics and key genes involved in hepatocellular carcinoma (HCC) are st...

Full description

Bibliographic Details
Main Authors: Yu-Jie Xu, Min-Ke He, Shuang Liu, Li-Chang Huang, Xiao-Yun Bu, Anna Kan, Ming Shi
Format: Article
Language:English
Published: BMC 2021-11-01
Series:Cancer Cell International
Subjects:
Online Access:https://doi.org/10.1186/s12935-021-02321-z
_version_ 1818842313187655680
author Yu-Jie Xu
Min-Ke He
Shuang Liu
Li-Chang Huang
Xiao-Yun Bu
Anna Kan
Ming Shi
author_facet Yu-Jie Xu
Min-Ke He
Shuang Liu
Li-Chang Huang
Xiao-Yun Bu
Anna Kan
Ming Shi
author_sort Yu-Jie Xu
collection DOAJ
description Abstract Background The accumulation of single nucleotide variants (SNVs) and the emergence of neoantigens can affect tumour proliferation and the immune microenvironment. However, the SNV-related immune microenvironment characteristics and key genes involved in hepatocellular carcinoma (HCC) are still unclear. We aimed to evaluate differences in the SNV-related immune microenvironment, construct a prognostic model and validate the key genes in vitro. Methods The categories of samples were defined by the expression of SNV score-related genes to evaluate the differences in mutational features, immune environment and prognosis. The survival model was constructed with survival-associated genes and verified in two independent test datasets. RCAN2, the key gene screened out for biofunction, was validated in vitro. Results IC2, among the three integrated clusters (IC1, IC2, IC3) classified by the 82 SNV score-related genes, was distinct from the rest in SNV score and immune cell infiltration, showing a better prognosis. Seven prognostic markers, HTRA3, GGT5, RCAN2, LGALS3, CXCL1, CLEC3B, and CTHRC1, were screened to construct a prognostic model. The survival model distinguished high-risk patients with poor prognoses in three independent datasets (log-rank P < 0.0001, 0.011, and 0.0068, respectively) with acceptable sensitivity and specificity. RCAN2 was inversely correlated with NK cell infiltration, and knockdown of RCAN2 promoted proliferation in HCC. Conclusions This study revealed the characteristics of the HCC SNV-associated subgroup and screened seven latent markers for their accuracy of prognosis. Additionally, RCAN2 was preliminarily proven to influence proliferation in HCC and it had a close relationship with NK cell infiltration in vitro. With the capability to predict HCC outcomes, the model constructed with seven key differentially expressed genes offers new insights into individual therapy.
first_indexed 2024-12-19T04:39:59Z
format Article
id doaj.art-1018776c018c4b11b068acfac8ee2848
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-12-19T04:39:59Z
publishDate 2021-11-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-1018776c018c4b11b068acfac8ee28482022-12-21T20:35:39ZengBMCCancer Cell International1475-28672021-11-0121111410.1186/s12935-021-02321-zConstruction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitroYu-Jie Xu0Min-Ke He1Shuang Liu2Li-Chang Huang3Xiao-Yun Bu4Anna Kan5Ming Shi6State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterAbstract Background The accumulation of single nucleotide variants (SNVs) and the emergence of neoantigens can affect tumour proliferation and the immune microenvironment. However, the SNV-related immune microenvironment characteristics and key genes involved in hepatocellular carcinoma (HCC) are still unclear. We aimed to evaluate differences in the SNV-related immune microenvironment, construct a prognostic model and validate the key genes in vitro. Methods The categories of samples were defined by the expression of SNV score-related genes to evaluate the differences in mutational features, immune environment and prognosis. The survival model was constructed with survival-associated genes and verified in two independent test datasets. RCAN2, the key gene screened out for biofunction, was validated in vitro. Results IC2, among the three integrated clusters (IC1, IC2, IC3) classified by the 82 SNV score-related genes, was distinct from the rest in SNV score and immune cell infiltration, showing a better prognosis. Seven prognostic markers, HTRA3, GGT5, RCAN2, LGALS3, CXCL1, CLEC3B, and CTHRC1, were screened to construct a prognostic model. The survival model distinguished high-risk patients with poor prognoses in three independent datasets (log-rank P < 0.0001, 0.011, and 0.0068, respectively) with acceptable sensitivity and specificity. RCAN2 was inversely correlated with NK cell infiltration, and knockdown of RCAN2 promoted proliferation in HCC. Conclusions This study revealed the characteristics of the HCC SNV-associated subgroup and screened seven latent markers for their accuracy of prognosis. Additionally, RCAN2 was preliminarily proven to influence proliferation in HCC and it had a close relationship with NK cell infiltration in vitro. With the capability to predict HCC outcomes, the model constructed with seven key differentially expressed genes offers new insights into individual therapy.https://doi.org/10.1186/s12935-021-02321-zHepatocellular carcinomaSingle nucleotide variantPrognostic modelImmune microenvironment
spellingShingle Yu-Jie Xu
Min-Ke He
Shuang Liu
Li-Chang Huang
Xiao-Yun Bu
Anna Kan
Ming Shi
Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro
Cancer Cell International
Hepatocellular carcinoma
Single nucleotide variant
Prognostic model
Immune microenvironment
title Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro
title_full Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro
title_fullStr Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro
title_full_unstemmed Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro
title_short Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro
title_sort construction of a single nucleotide variant score related gene based prognostic model in hepatocellular carcinoma analysis of multi independent databases and validation in vitro
topic Hepatocellular carcinoma
Single nucleotide variant
Prognostic model
Immune microenvironment
url https://doi.org/10.1186/s12935-021-02321-z
work_keys_str_mv AT yujiexu constructionofasinglenucleotidevariantscorerelatedgenebasedprognosticmodelinhepatocellularcarcinomaanalysisofmultiindependentdatabasesandvalidationinvitro
AT minkehe constructionofasinglenucleotidevariantscorerelatedgenebasedprognosticmodelinhepatocellularcarcinomaanalysisofmultiindependentdatabasesandvalidationinvitro
AT shuangliu constructionofasinglenucleotidevariantscorerelatedgenebasedprognosticmodelinhepatocellularcarcinomaanalysisofmultiindependentdatabasesandvalidationinvitro
AT lichanghuang constructionofasinglenucleotidevariantscorerelatedgenebasedprognosticmodelinhepatocellularcarcinomaanalysisofmultiindependentdatabasesandvalidationinvitro
AT xiaoyunbu constructionofasinglenucleotidevariantscorerelatedgenebasedprognosticmodelinhepatocellularcarcinomaanalysisofmultiindependentdatabasesandvalidationinvitro
AT annakan constructionofasinglenucleotidevariantscorerelatedgenebasedprognosticmodelinhepatocellularcarcinomaanalysisofmultiindependentdatabasesandvalidationinvitro
AT mingshi constructionofasinglenucleotidevariantscorerelatedgenebasedprognosticmodelinhepatocellularcarcinomaanalysisofmultiindependentdatabasesandvalidationinvitro